It occurs when fluid builds up behind the eye, but there is no tear. It may be the result of injury, trauma, or another condition.

In 10-15% of people with dry AMD, the condition progresses to wet AMD. Wet AMD results from abnormal blood vessels growing behind the macula and then leaking fluid, which scars the macula.

Kiora Pharmaceuticals, Inc. today announced it received regulatory approval to initiate KLARITY, a Phase 2 clinical trial to investigate KIO-104 in patients with retinal macular edema, a condition ...